Photobiomodulation Therapy & Acupuncture
Photobiomodulation therapy (PBMT), also known as low-level light therapy (LLLT), LED, or red light therapy can be integrated directly into treatment plans, alongside acupuncture. By delivering targeted red and near-infrared photons (ranging from 630 nm to 1070 nm) deep into biological tissue, this non-invasive, NASA-derived multi-wavelength technology stimulates Cytochrome C Oxidase within cellular mitochondria. This mechanism boosts ATP cellular energy, improves microvascular blood flow, and shifts macrophage pathways to actively resolve inflammation and accelerate tissue repair.
Key clinical applications supported by research include:
Neurology & Brain Health: Reduces neuroinflammation, boosts cerebral blood flow, and supports recovery from traumatic brain injury and cognitive decline.
Pain & Joint Relief: Relieves chronic pain, neuropathy, fibromyalgia, and arthritis while speeding post-surgical and muscle recovery.
Mood & Mental Well-Being: Enhances brain cell metabolism, increases endorphins, and helps ease symptoms of depression, anxiety, and post-viral fog.
Skin Rejuvenation & Regeneration: Stimulates collagen and stem cell proliferation to smooth fine lines, reduce hyperpigmentation, fade scars, calm acne or eczema, and promote hair growth.
PBMT is gentle, painless, and requires zero downtime. It can be provided as a standalone treatment or seamlessly combined with acupuncture to accelerate healing from within. Contact Bethesda Acupuncture today at 301.880.3232 to schedule your evaluation and learn how light therapy can support your health goals.
References:
BioLED & Aging Research Synthesis. (2025). Photobiomodulation and Cytochrome C Oxidase: Mechanisms, ATP Production, and Inflammatory Cascades. National Institute on Aging (NIA) GeroScience Report.
Chen, G., Xiao, Y., Song, Y., et al. (2025). Transcranial photobiomodulation promotes traumatic brain injury recovery via modulating glial cell polarization and neuroinflammation. Journal of Neurotrauma, 42(3), 210–225.
Cardoso, F. F. S., Salehpour, F., et al. (2022). Photobiomodulation for the treatment of neuroinflammation: A systematic review of controlled laboratory animal studies. Frontiers in Neuroscience, 16, 1006031.
Frontiers in Integrative Neuroscience Review. (2026). Photobiomodulation in chronic pain: A systematic review of clinical trials in neuropathic and musculoskeletal conditions. Frontiers in Integrative Neuroscience, 20, 1717372.
Geroscience Review Group. (2024). Photobiomodulation in the aging brain: A systematic review from animal models to humans. Geroscience, 46(6), 6583–6623.
Lee, T. L., Ding, Z., & Chan, A. S. (2023). Can transcranial photobiomodulation improve cognitive function? A systematic review of human studies. Translational Psychiatry, 13(1), 142.
Ponnusamy, S., et al. (2026). Photobiomodulation activates coordinated signaling networks to modulate inflammation, adaptive stress, and tissue healing via redox-mediated NF$\kappa$B–TGF-$\beta$1–ATF-4 axis. PMC Integrative Medicine, PMC12785302.
Systematic Review on Fibromyalgia & PBMT. (2025). Effectiveness of photobiomodulation therapy in the management of fibromyalgia syndrome: A systematic review and meta-analysis. Journal of Clinical Medicine, 14(4), 1182.
Vieira, W. F., Gersten, M., & Cassano, P. (2023). Tolerability and safety profile of transcranial photobiomodulation in neuropsychiatric disorders: A pooled systematic review. Journal of Psychiatric Research, 165, 88–97.
Wound Healing & Skin Regeneration Review. (2024). Photobiomodulation as a multimodal therapy to enhance wound healing and skin regeneration. Medical Lasers, 13(2), 45–58.
Zhao, C., et al. (2024). Transcranial photobiomodulation for brain diseases: Review of animal and human studies including mechanisms and emerging trends. Neurophotonics, 11(1), 010601.
This website provides general information only. Content does not constitute medical advice. Consult a healthcare professional for medical guidance.